AFP and hepatocellular carcinoma: The study reported that the combination of three factors, which included the up-to-11 criteria, serum AFP, and albumin-bilirubin (ALBI) grade, was an independent predictor to estimate overall survival (OS) in BCLC-B HCC patients undergoing TACE.